Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOCEPREVIR vs BOSUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOCEPREVIR vs BOSUTINIB: Safety Overview

Metric BOCEPREVIR BOSUTINIB
Total FAERS Reports 2,078 7,777
Deaths Reported 112 680
Death Rate 5.4% 8.7%
Hospitalizations 478 1,675
Average Patient Age 53.1 yrs 64.7 yrs
% Female Patients 44.4% 51.8%
FDA Approval Date May 13, 2011 May 23, 2025
Manufacturer N/A U.S. Pharmaceuticals
Route N/A ORAL
Marketing Status Discontinued Prescription